Details of the Drug

General Information of Drug (ID: DMM2M1L)

Drug Name

P2045

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 1/2	[1]
Small-cell lung cancer	2C25.Y	Phase 1/2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C12H22O2
Canonical SMILES: CCCCCC1CCC(CC1)C(=O)O
InChI: 1S/C12H22O2/c1-2-3-4-5-10-6-8-11(9-7-10)12(13)14/h10-11H,2-9H2,1H3,(H,13,14)
InChIKey: RVLAXPQGTRTHEV-UHFFFAOYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02030184) Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas. U.S. National Institutes of Health.